SNDX · Categories · Form 3

SNDX - SEC Form 3 initial insider statements

Syndax Pharmaceuticals Inc. (SNDX) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for SNDX

• 390d
  New insider Botwood Nicholas A.J. claimed ownership of 23,400 shares (SEC Form 3)

  3 - Syndax Pharmaceuticals Inc (0001395937) (Issuer)
• 755d
  SEC Form 3 filed by new insider Rizo Aleksandra

  3 - Syndax Pharmaceuticals Inc (0001395937) (Issuer)
• 1155d
  SEC Form 3 filed by new insider Gallagher Neil

  3 - Syndax Pharmaceuticals Inc (0001395937) (Issuer)
• 1283d
  SEC Form 3 filed by new insider Sabus Steve M

  3 - Syndax Pharmaceuticals Inc (0001395937) (Issuer)
• 1456d
  SEC Form 3 filed by new insider Goldan Keith A.

  3 - Syndax Pharmaceuticals Inc (0001395937) (Issuer)
• 1560d
  SEC Form 3 filed by new insider Madigan Catherine

  3 - Syndax Pharmaceuticals Inc (0001395937) (Issuer)
• 1679d
  SEC Form 3 filed by new insider Nolte Alexander

  3 - Syndax Pharmaceuticals Inc (0001395937) (Issuer)
• 1727d
  SEC Form 3 filed by new insider Huber Martin H. Jr.

  3 - Syndax Pharmaceuticals Inc (0001395937) (Issuer)

Other SNDX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends